The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1
Open accessAbstract
In the present study, we showed that Chinese hamster ovary (CHO) cells transfected with human central cannabinoid receptor (CB1) exhibit high constitutive activity at both levels of mitogen-activated protein kinase (MAPK) and adenylyl cyclase. These activities could be blocked by the CB1-selective ligand, SR 141716A, that functions as an inverse agonist. Moreover, binding studies showed that guanine nucleotides decreased the binding of the agonist CP-55,940, an effect usually observed with agonists, whereas it enhanced the binding of SR 141716A, a property of inverse agonists. Unexpectedly, we found that CB1-mediated effects of SR 141716A included inhibition of MAPK activation by pertussis toxin-sensitive receptor-tyrosine kinase such as insulin or insulin-like growth factor 1 receptors but not by pertussis toxin-insensitive receptor-tyrosine kinase such as the fibroblast growth factor receptor. We also observed similar results when cells were stimulated with Mas-7, a mastoparan analog, that directly activates the Gi protein. Furthermore, SR 141716A inhibited guanosine 5'-0-(thiotriphosphate) uptake induced by CP-55,940 or Mas-7 in CHO-CB1 cell membranes. This indicates that, in addition to the inhibition of autoactivated CB1, SR 141716A can deliver a biological signal that blocks the Gi protein and consequently abrogates most of the Gi-mediated responses. By contrast, SR 141716A had no effect on MAPK activation by insulin or IGF1 in CHO cells lacking CB1 receptors, ruling out the possibility of a direct interaction of SR 141716A with the Gi protein. This supports the notion that the Gi protein may act as a negative intracellular signaling cross-talk molecule. From these original results, which considerably enlarge the biological properties of the inverse agonist, we propose a novel model for receptor/ligand interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Self-citationGaliègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Self-citationRole of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
The MAP kinase cascade is essential for diverse signal transduction pathways
Nishida, E., & Gotoh, Y. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90019-j · Cited by 1,076
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
Parma, J., Duprez, L., Sande, J. V., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., & Vassart, G. (1993) · Nature · doi:10.1038/365649a0 · Cited by 918
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
Lefkowitz, R. J., Cotecchia, S., Samama, P., & Costa, T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90048-o · Cited by 792
Shenker, A., Laue, L., Kosugi, S., Merendino, J. J., Minegishi, T., & Cutler, G. B. (1993) · Nature · doi:10.1038/365652a0 · Cited by 745
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Transformation of rat cells by DNA of human adenovirus 5
Graham, F. L., & Van Der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90163-3 · Cited by 652
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631
Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Interaction of Convulsive Ligands with Benzodiazepine Receptors
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., & Petersen, E. N. (1982) · Science · doi:10.1126/science.6281892 · Cited by 547
Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 543
Self-citationCosta, T., & Herz, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7321 · Cited by 536
Kameshita, I., & Fujisawa, H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90181-4 · Cited by 458
Bond, R. A., Leff, P., Johnson, T. D., Milano, C. A., Rockman, H. A., McMinn, T. R., Apparsundaram, S., Hyek, M. F., Kenakin, T. P., Allen, L. F., et al. (1995) · Nature · doi:10.1038/374272a0 · Cited by 416
Karin, M. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90035-3 · Cited by 394
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 375
Inverse agonist activity of beta-adrenergic antagonists.
Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., & Bouvier, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10022-9 · Cited by 372
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
Sevetson, B. R., Kong, X., & Lawrence, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10305 · Cited by 371
Hawes, B. E., Luttrell, L. M., van Biesen, T., & Lefkowitz, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12133 · Cited by 369
Cannabinoid‐receptor expression in human leukocytes
BOUABOULA, M., RINALDI, M., CARAYON, P., CARILLON, C., DELPECH, B., SHIRE, D., LE FUR, G., & CASELLAS, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 367
Self-citationThe classification of seven transmembrane receptors in recombinant expression systems.
Kenakin, T. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06948-0 · Cited by 270
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi, M., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46876-7 · Cited by 265
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 255
Barker, E. L., Westphal, R. S., Schmidt, D., & Sanders-Bush, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32625-x · Cited by 254
Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 248
Insulin action impaired by deficiency of the G-protein subunit Giα2
Moxham, C. M., & Malbon, C. C. (1996) · Nature · doi:10.1038/379840a0 · Cited by 214
Schlegel, W., Kempner, E. S., & Rodbell, M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50575-5 · Cited by 210
Levis, M. J., & Bourne, H. R. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.5.1297 · Cited by 208
Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Touhara, K., & Lefkowitz, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16495 · Cited by 199
Leyte, A., Barr, F. A., Kehlenbach, R. H., & Huttner, W. B. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05585.x · Cited by 182
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi-Carmona, M., Shire, D., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175
Self-citationRothenberg, P., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37623-9 · Cited by 156
Rinaldi, M. L., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J.-C., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00085-9 · Cited by 132
Self-citationCharacterization of two cloned human CB1 cannabinoid receptor isoforms.
Rinaldi, M. L., Calandra, B., Shire, D. J., Bouaboula, M., Oustric, D., Barth, F., Casellas, P., Ferrara, P., & Fur, G. L. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20674-7 · Cited by 124
Self-citationSelley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111
Ueki, K., Matsuda, S., Tobe, K., Gotoh, Y., Tamemoto, H., Yachi, M., Akanuma, Y., Yazaki, Y., Nishida, E., & Kadowaki, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40745-9 · Cited by 97
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
Westphal, R. S., & Sanders‐Bush, E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09836-0 · Cited by 86
Sa, G., & Fox, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41851-5 · Cited by 83
Gil, J., Higgins, T., & Rozengurt, E. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.113.4.943 · Cited by 77
Milligan, G., Carr, C., Gould, G. W., Mullaney, I., & Lavan, B. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38138-9 · Cited by 67
Valiquette, M., Parent, S., Loisel, T. P., & Bouvier, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00241.x · Cited by 59
Analysis of inverse agonism at the δ opioid receptor after expression in Rat 1 fibroblasts
Mullaney, I., CARR, I. C., & Milligan, G. (1996) · Biochemical Journal · doi:10.1042/bj3150227 · Cited by 52
Harada, S., Smith, R. M., Smith, J. A., White, M. F., & Jarett, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30222 · Cited by 50
GTP‐binding protein‐activator sequences in the insulin receptor
Okamoto, T., Okamoto, T., Murayama, Y., Hayashi, Y., Ogata, E., & Nishimoto, I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81700-a · Cited by 31
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Metadata
- Authors
- Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J.-P., Le Fur, G., & Casellas, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-08
- Volume
- 272
- Issue
- 35
- Pages
- 22330-22339
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127160263
- Cited by
- 461
- References
- 52
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.